ArticleCell death & disease2018

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.

Nathan Redlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.